ANIP FY 2011 Earnings — ANI Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

ANIPANI Pharmaceuticals, Inc.

$2B

FY 2011 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$435,160-82.4% YoY

Gross Profit

$385,16088.5% margin

Operating Income

-$51M-11703.0% margin

Net Income

-$52M-11859.7% margin

EPS (Diluted)

$-18.88

Cash Flow

Operating Cash Flow

-$48M

Free Cash Flow

-$49M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$62M

Total Liabilities

$25M

Stockholders' Equity

$38M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$435,160	$2M	-82.4%
Gross Profit	$385,160	$2M	-82.5%
Operating Income	-$51M	-$44M	-16.8%
Net Income	-$52M	-$46M	-11.7%